Possibilities of using rosuvastatin to achieve target level of low-density lipoprotein cholesterol in clinical practice
Statins are the cornerstone of therapy for hypercholesterolemia and coronary artery disease. A large number of studies have demonstrated the effectiveness of lipid-lowering therapy in preventing the progression of atherosclerosis and the development of cardiovascular diseases. The original rosuvasta...
Saved in:
Main Authors: | Yuliia A. Prus (Author), Igor V. Sergienko (Author) |
---|---|
Format: | Book |
Published: |
LLC "MEDIAFORMAT",
2020-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease
by: A. E. Nikitin, et al.
Published: (2020) -
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
by: Niki Katsiki, et al.
Published: (2023) -
Monocyte/high-density lipoprotein cholesterol, neutrophil/high-density lipoprotein cholesterol, and lymphocyte/high-density lipoprotein cholesterol ratios as new inflammatory markers in rosacea
by: Bülent Nuri Kalaycı
Published: (2023) -
Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome.
by: Hope H Biswas, et al.
Published: (2015) -
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b for cardiovascular risk assessment - What is the right choice?
by: Shrikanth N Hegde
Published: (2020)